{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T16:05:24Z","timestamp":1747238724708},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1007\/s11934-005-0026-1","type":"journal-article","created":{"date-parts":[[2007,6,5]],"date-time":"2007-06-05T18:56:25Z","timestamp":1181069785000},"page":"290-295","source":"Crossref","is-referenced-by-count":7,"title":["Saw palmetto and finasteride in the treatment of category-iii prostatitis\/chronic pelvic pain syndrome"],"prefix":"10.1007","volume":"6","author":[{"given":"Jennifer","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis E.","family":"Te","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"26_CR1","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/S0022-5347(01)63564-X","volume":"159","author":"NM Collins","year":"1998","unstructured":"Collins NM, Stafford RS, O\u2019Leary MP, Barry MJ: How common is prostatitis? A national survey of physician visits. J Urol 1998, 159:1224\u20131228.","journal-title":"J Urol"},{"key":"26_CR2","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1001\/archinte.164.11.1231","volume":"164","author":"EA Calhoun","year":"2004","unstructured":"Calhoun EA, McNaughton Collins M, Pontari MA, et al.:The economic impact of chronic prostatitis. Arch Intern Med 2004, 164:1231\u20131236.","journal-title":"Arch Intern Med"},{"key":"26_CR3","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/j.1442-2042.2004.00842.x","volume":"11","author":"JH Ku","year":"2004","unstructured":"Ku JH, Kwak C, Oh SJ, et al.: Influence of pain and urinary symptoms on quality of life in young men with chronic prostatitis-like symptoms. Int J Urol 2004, 11:489\u2013493.","journal-title":"Int J Urol"},{"key":"26_CR4","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1097\/01.ju.0000132797.63480.44","volume":"172","author":"JA Turner","year":"2004","unstructured":"Turner JA, Ciol MA, Von Korff M, Berger R: Prognosis of patients with new prostatitis\/pelvic pain syndrome episodes. J Urol 2004, 172:538\u2013541.","journal-title":"J Urol"},{"key":"26_CR5","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0022-5347(17)36940-9","volume":"148","author":"LM Shortliffe","year":"1992","unstructured":"Shortliffe LM, Sellers RG, Schachter J: The characterization of nonbacterial prostatitis: search for an etiology. J Urol 1992, 148:1461\u20131466.","journal-title":"J Urol"},{"key":"26_CR6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0022-5347(05)67987-6","volume":"163","author":"WW Hochreiter","year":"2000","unstructured":"Hochreiter WW, Duncan JL, Schaeffer AJ: Evaluation of the bacterial flora of the prostate using a 16S rRNA gene-based polymerase chain reaction. J Urol 2000, 163:127\u2013130.","journal-title":"J Urol"},{"key":"26_CR7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/pros.10218","volume":"55","author":"MJ Leskinen","year":"2003","unstructured":"Leskinen MJ, Rantakokko-Jalava K, Manninen R, et al.:Negative bacterial polymerase chain reaction (PCR) findings in prostate tissue from patients with symptoms of chronic pelvic pain syndrome (CPPS) and localized prostate cancer. Prostate 2003, 55:105\u2013110.","journal-title":"Prostate"},{"key":"26_CR8","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/S0022-5347(05)63958-4","volume":"169","author":"JC Lee","year":"2003","unstructured":"Lee JC, Muller CH, Rothman I, et al.: Prostate biopsy culture findings of men with chronic pelvic pain syndrome do not differ from health controls. J Urol 2003, 169:584\u2013588.","journal-title":"J Urol"},{"key":"26_CR9","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0022-5347(17)32309-1","volume":"152","author":"SA Kaplan","year":"1995","unstructured":"Kaplan SA, Te AE, Jacobs BZ: Urodynamic evidence of vesical neck obstruction in men with \u201cchronic non-bacterial\u201d prostatitis and the therapeutic role of the endoscopic incision of the bladder neck. J Urol 1995, 152:2063\u20132065.","journal-title":"J Urol"},{"key":"26_CR10","first-page":"897","volume":"157","author":"SA Kaplan","year":"1997","unstructured":"Kaplan SA, Santarosa RP, D\u2019Alisera PM, et al.: \u201cPseudo\u201d dyssynergia (contraction of the external sphincter during voiding) misdiagnosed as \u201cchronic non-bacterial prostatitis\u201d and the role of biofeedback as a therapeutic option. J Urol 1997, 157:897\u2013901.","journal-title":"J Urol"},{"key":"26_CR11","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/S0090-4295(96)00038-6","volume":"47","author":"SA Kaplan","year":"1996","unstructured":"Kaplan SA, Ikeguchi EF, Santarosa RP, et al.: Etiology of voiding dysfunction in men less than 50 years of age. Urology 1996, 47:836\u2013839.","journal-title":"Urology"},{"key":"26_CR12","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/S0094-0143(05)70056-2","volume":"25","author":"JC Nickel","year":"1998","unstructured":"Nickel JC: Effective office management of chronic prostatitis. Urol Clin North Am 1998, 25:677\u2013684.","journal-title":"Urol Clin North Am"},{"key":"26_CR13","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/01.ju.0000131592.98562.16","volume":"172","author":"JC Nickel","year":"2004","unstructured":"Nickel JC, Downey J, Ardern D, et al.: Failure of monotherapy strategy for difficult chronic prostatitis\/chronic pelvic pain syndrome. J Urol 2004, 172:551\u2013554.","journal-title":"J Urol"},{"key":"26_CR14","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1097\/01.ju.0000117811.40279.19","volume":"171","author":"JC Nickel","year":"2004","unstructured":"Nickel JC, Narayan P, McKay J, Doyle C: Treatment of chronic prostatitis\/chronic pelvic pain syndrome with tamsulosin: a randomized, double-blind trial. J Urol 2004, 171:1594\u20131597.","journal-title":"J Urol"},{"key":"26_CR15","doi-asserted-by":"crossref","first-page":"581","DOI":"10.7326\/0003-4819-141-8-200410190-00005","volume":"141","author":"RB Alexander","year":"2004","unstructured":"Alexander RB, Propert KJ, Schaeffer AJ, et al.: Ciprofloxacin or tamsulosin in men with chronic prostatitis\/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med 2004, 141:581\u2013589.","journal-title":"Ann Intern Med"},{"key":"26_CR16","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1056\/NEJM199809173391210","volume":"339","author":"M Angell","year":"1998","unstructured":"Angell M, Kassirer JP: Alternative medicine-the risks of untested and unregulated remedies. N Engl J Med 1998, 339:839\u2013841.","journal-title":"N Engl J Med"},{"key":"26_CR17","unstructured":"Consumer Report: Herbal rx for prostate problems: Saw palmetto pills may help\u2014if they contain enough of the right stuff. September 2000."},{"key":"26_CR18","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/S0022-5347(05)64850-1","volume":"168","author":"AH Feifer","year":"2002","unstructured":"Feifer AH, Fleshner NE, Klotz L: Analytical accuracy and reliability of commonly used nutritional supplements in prostate disease. J Urol 2002, 168:150\u2013154.","journal-title":"J Urol"},{"key":"26_CR19","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1016\/S0022-5347(05)67631-8","volume":"163","author":"GS Gerber","year":"2000","unstructured":"Gerber GS: Saw palmetto for the treatment of men with lower urinary tract symptoms. J Urol 2000, 163:1408\u20131412.","journal-title":"J Urol"},{"key":"26_CR20","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1097\/01.ju.0000132798.48067.23","volume":"172","author":"DA Shoskes","year":"2004","unstructured":"Shoskes DA, Landis JR, Wang Y, et al.: Impact of post-ejaculatory pain in men with category III chronic prostatitis\/chronic pelvic pain syndrome. J Urol 2004, 172:542\u2013547.","journal-title":"J Urol"},{"key":"26_CR21","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1464-410X.1993.tb15988.x","volume":"71","author":"EW Rugendorff","year":"1993","unstructured":"Rugendorff EW, Weidner W, Ebeling L, Buck AC: Results of treatment with pollen extract (Cernilton N) in chronic prostatitis and prostadynia. Br J Urol 1993, 71:433\u2013438.","journal-title":"Br J Urol"},{"key":"26_CR22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/(SICI)1097-0045(19981001)37:2<77::AID-PROS3>3.0.CO;2-I","volume":"37","author":"Silverio F Di","year":"1998","unstructured":"Di Silverio F, Monti S, Sciarra A, et al.: Effects of long-term treatment with Serenoa repens (Permixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia. Prostate 1998, 37:77\u201383.","journal-title":"Prostate"},{"key":"26_CR23","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S0022-5347(01)62141-4","volume":"161","author":"PN Span","year":"1999","unstructured":"Span PN, Voller MC, Smals AG, et al.: Selectivity of finasteride as an in vivo inhibitor of 5-alpha reductase isoenzyme activity in the human prostate. J Urol 1999, 161:332\u2013337.","journal-title":"J Urol"},{"key":"26_CR24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/0960-0760(95)00167-0","volume":"57","author":"PN Span","year":"1996","unstructured":"Span PN, Benraad ThJ, Sweep CG, Smals AG: Kinetic analysis of steroid 5-alpha reductase activity at neutral pH in benign prostatic hyperplasic tissue: evidence for type I isozyme in the human prostate. J Steroid Biochem Mol Biol 1996, 57:103\u2013108.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"26_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/pros.2990220107","volume":"22","author":"L Rhodes","year":"1993","unstructured":"Rhodes L, Primka RL, Berman C, et al.: Comparison of finasteride (Proscar), a 5-alpha reductase inhibitor, and various commercial plant extracts in in vitro and in vivo 5-alpha reductase inhibition. Prostate 1993, 22:43\u201351.","journal-title":"Prostate"},{"key":"26_CR26","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000475388","volume":"26","author":"G Strauch","year":"1994","unstructured":"Strauch G, Perles P, Vergult G, et al.: Comparison of finasteride and Serenoa repens (Permixon) in the inhibitions of 5-alpha reductase in healthy male volunteers. Eur Urol 1994, 26:247\u2013252.","journal-title":"Eur Urol"},{"key":"26_CR27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000474863","volume":"21","author":"F Di Silverio","year":"1992","unstructured":"Di Silverio F, D\u2019Eramo G, Lubrano C, et al.: Evidence that Serenoa repens extract displays an antiestrogenic activity in prostatic tissue of benign prostatic hypertrophy patients. Eur Urol 1992, 21:309\u2013314.","journal-title":"Eur Urol"},{"key":"26_CR28","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/(SICI)1097-0045(199610)29:4<231::AID-PROS4>3.0.CO;2-E","volume":"29","author":"JC Carraro","year":"1996","unstructured":"Carraro JC, Raynaud JP, Koch G, et al.: Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostatic hyperplasia: a randomized, international study of 1098 patients. Prostate 1996, 29:231\u2013242.","journal-title":"Prostate"},{"key":"26_CR29","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/0960-0760(95)00134-L","volume":"54","author":"C Iehle","year":"1995","unstructured":"Iehle C, Delos S, Guirou O, et al.: Human prostatic steroid 5 alpha reductase isoforms: a comparative study of selective inhibitors. J Steroid Biochem Mol Biol 1995, 54:273\u2013279.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"26_CR30","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/0022-4731(84)90264-4","volume":"20","author":"C Sultan","year":"1984","unstructured":"Sultan C, Terraza A, Devillier C, et al.: Inhibition of androgen metabolism and binding by a liposterolic extraction of \u201cSerenoa repens B\u201d\u201d in human foreskin fibroblasts. J Steroid Biochem 1984, 20:515\u2013519.","journal-title":"J Steroid Biochem"},{"key":"26_CR31","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/0022-4731(84)90265-6","volume":"20","author":"E Carilla","year":"1984","unstructured":"Carilla E, Briley M, Fauran F, et al.: Binding of permixon, a new treatment for prostatic benign hyperplasia, to the cytosolic androgen receptor in the rat prostate. J Steroid Biochem 1984, 20:521\u2013523.","journal-title":"J Steroid Biochem"},{"key":"26_CR32","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/(SICI)1097-0045(199610)29:4<219::AID-PROS3>3.0.CO;2-6","volume":"29","author":"L Ravenna","year":"1996","unstructured":"Ravenna L, Di Silverio F, Russo MA, et al.: Effects of the lipidosterolic extract of Serenoa repens (Permixon) on human prostatic cell lines. Prostate 1996, 29:219\u2013230.","journal-title":"Prostate"},{"key":"26_CR33","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1159\/000019570","volume":"33","author":"M Paubert-Braquet","year":"1998","unstructured":"Paubert-Braquet M, Cousse H, Raynaud JP, et al.: Effect of the lipidosterolic extract of Serenoa repens (Permixon) and its major components on basic fibroblast growth factor-induced proliferation of cultures of human prostate biopsies. Eur Urol 1998, 33:340\u2013347.","journal-title":"Eur Urol"},{"key":"26_CR34","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1006\/cbir.2001.0779","volume":"25","author":"WH Goldman","year":"2001","unstructured":"Goldman WH, Sharma AL, Currier SJ, et al.: Saw palmetto berry extract inhibits cell growth and cox-2 expression in prostatic cancer cells. Cell Biol Int 2001, 25:1117\u20131124.","journal-title":"Cell Biol Int"},{"key":"26_CR35","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1210\/en.2003-1716","volume":"145","author":"TL Wadsworth","year":"2004","unstructured":"Wadsworth TL, Carroll JM, Mallinson RA, et al.: Saw palmetto extract suppresses insulin-like growth factor-I signaling and induces stress-activated protein kinase\/c-Jun N-terminal kinase phosphorylation in human prostate epithelial cells. Endocrinology 2004, 145:3205\u20133214.","journal-title":"Endocrinology"},{"key":"26_CR36","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/BF02255223","volume":"2","author":"P Vacher","year":"1995","unstructured":"Vacher P, Prevarskaya N, Skryma R, et al.: The liposterolic extract from Serenoa repens interferes with prolactin receptor signal transduction. J Biomed Sci 1995, 2:357\u2013365.","journal-title":"J Biomed Sci"},{"key":"26_CR37","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/(SICI)1097-0045(19990215)38:3<208::AID-PROS5>3.0.CO;2-4","volume":"38","author":"M Goepel","year":"1999","unstructured":"Goepel M, Hecker U, Krege S, et al.: Saw palmetto extracts potently and noncompetitively inhibit human alpha1-adrenoceptors in vitro. Prostate 1999, 38:208\u2013215.","journal-title":"Prostate"},{"key":"26_CR38","first-page":"97","volume":"48","author":"M Grasso","year":"1995","unstructured":"Grasso M, Montesano A, Buonaguidi A, et al.: Comparative effects of alfuzosin versus Serenoa repens in the treatment of symptomatic benign prostatic hyperplasia. Arch Esp Urol 1995, 48:97\u2013103.","journal-title":"Arch Esp Urol"},{"key":"26_CR39","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/S0090-4295(01)01442-X","volume":"58","author":"GS Gerber","year":"2001","unstructured":"Gerber GS, Kuznetsov D, Johnson BC, Burstein JD:Randomized, double-blind, placebo-controlled trial of saw palmetto in men with lower urinary tract symptoms. Urology 2001, 58:960\u2013963.","journal-title":"Urology"},{"key":"26_CR40","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/S0022-5347(05)67641-0","volume":"163","author":"LS Marks","year":"2000","unstructured":"Marks LS, Partin AW, Epstein JI, et al.: Effects of saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia. J Urol 2000, 163:1451\u20131456.","journal-title":"J Urol"},{"key":"26_CR41","first-page":"CD001423","volume":"2","author":"T Wilt","year":"2000","unstructured":"Wilt T, Ishani A, Stark G, et al.: Serenoa repens for benign prostatic hyperplasia. Cochrane Database Syst Rev 2000, 2:CD001423.","journal-title":"Cochrane Database Syst Rev"},{"issue":"suppl","key":"26_CR42","first-page":"257","volume":"159","author":"F Lowe","year":"1998","unstructured":"Lowe F, Robertson C, Roehrborn A, et al.: Meta-analysis of clinical trials of Permixon. J Urol 1998, 159(suppl):257.","journal-title":"J Urol"},{"key":"26_CR43","doi-asserted-by":"crossref","first-page":"42","DOI":"10.7326\/0003-4819-136-1-200201010-00010","volume":"136","author":"E Ernst","year":"2002","unstructured":"Ernst E: The risk-benefit profile of commonly used herbal therapies: St. John\u2019s Wort, ginseng, Echinacea, saw palmetto, and Kava. Ann Intern Med 2002, 136:42\u201353.","journal-title":"Ann Intern Med"},{"key":"26_CR44","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1111\/j.1464-410X.2003.04766.x","volume":"93","author":"JC Nickel","year":"2004","unstructured":"Nickel JC, Downey J, Pontari MA, et al.: A randomized, placebo-controlled, multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis). BJU Int 2004, 93:991\u2013995. This is the first placebo-controlled study examining finasteride in men with category IIIA chronic nonbacterial prostatitis.","journal-title":"BJU Int"},{"key":"26_CR45","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/01.ju.0000101487.83730.80","volume":"171","author":"SA Kaplan","year":"2004","unstructured":"Kaplan SA, Volpe MA, Te AT: A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis\/chronic pelvic pain syndrome. J Urol 2004, 171:284\u2013288. This is the first prospective trial evaluating finasteride in men with category IIIA chronic nonbacterial prostatitis.","journal-title":"J Urol"},{"key":"26_CR46","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S0090-4295(00)01052-9","volume":"57","author":"LS Marks","year":"2001","unstructured":"Marks LS, Hess DL, Dorey FJ, et al.: Tissue effects of saw palmetto and finasteride: use of biopsy cores for in situ quantification of prostatic androgens. Urology 2001, 57:999\u20131005. This is the first study that evaluates and compares the tissue effects of saw palmetto and finasteride in humans with biopsy cores.","journal-title":"Urology"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-005-0026-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11934-005-0026-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-005-0026-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-005-0026-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T11:58:44Z","timestamp":1652615924000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11934-005-0026-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["26"],"URL":"https:\/\/doi.org\/10.1007\/s11934-005-0026-1","relation":{},"ISSN":["1527-2737","1534-6285"],"issn-type":[{"value":"1527-2737","type":"print"},{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}